The first case report providing evidence of the contributory role of TP53 mutation in the development of dedifferentiated solitary fibrous tumor (dSFT), by describing a case of a unique and rare presentation of dSFT in the nasal cavity, was in 2011 [19]. The gene discussed is TP53; the disease is solitary fibrous tumor.